Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza

European Respiratory Journal

Volumn 36, Issue 6, 2010, Pages 1346-1354

  Schouten, M ^a   Van Der Sluijs, K F ^a   Roelofs, J J T H ^a   Levie, M ^a   Van't Veer, C ^a   Van Der Poll, T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Blood coagulation; Factor V Leiden; Infection; Inflammation; Influenza; Protein C

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; THROMBIN ANTITHROMBIN COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DISEASE SEVERITY; FIBRIN DEPOSITION; FIBRINOLYSIS; GENE MUTATION; HETEROZYGOTE; HISTOPATHOLOGY; HOMOZYGOTE; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LETHAL DOSE; LETHALITY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; VIRUS LOAD; WILD TYPE;

ANIMALS; ANTITHROMBINS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; FACTOR V; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HETEROZYGOTE; HOMOZYGOTE; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUNG; MALE; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; POINT MUTATION; SEVERITY OF ILLNESS INDEX; THROMBIN; VIRAL LOAD;

EID: 78649723309     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00204909     Document Type: Article

References (29)

1. Dushoff J, Plotkin JB, Viboud C, et al. Mortality due to influenza in the United States: an annualized regression approach using multiple-cause mortality data. Am J Epidemiol 2006; 163: 181-187.
2. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325: 197-201.
3. Blanquer J, Blanquer R, Borras R, et al. Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study. Thorax 1991; 46: 508-511.
4. Lauderdale TL, Chang FY, Ben RJ, et al. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir Med 2005; 99: 1079-1086.
5. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351: 2611-2618.
6. Schouten M, Wiersinga WJ, Levi M, et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83: 536-545.
7. Keller TT, Van der Sluijs KF, De Kruif MD, et al. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res 2006; 99: 1261-1269.
8. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in bloodcoagulation factor-V associated with resistance to activated protein-C. Nature 1994; 369: 64-67.
9. Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-1508.
10. Majerus PW. Human genetics. Bad blood by mutation. Nature 1994; 369: 14-15.
11. Gopel W, Gortner L, Kohlmann T, et al. Low prevalence of large intraventricular haemorrhage in very low birthweight infants carrying the factor V Leiden or prothrombin G20210A mutation. Acta Paediatr 2001; 90: 1021-1024.
12. Gopel W, Ludwig M, Junge AK, et al. Selection pressure for the factor-V-Leiden mutation and embryo implantation. Lancet 2001; 358: 1238-1239.
13. Kerlin BA, Yan SB, Isermann BH, et al. Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 2003; 102: 3085-3092.
14. Hofstra JJ, Schouten M, Levi M. Thrombophilia and outcome in severe infection and sepsis. Semin Thromb Hemost 2007; 33: 604-609.
15. Brüggemann LW, Schoenmakers SH, Groot AP, et al. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice. Crit Care Med 2006; 34: 2201-2206.
16. Sun H, Wang X, Degen JL, et al. Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood 2008; 113: 1358-1364.
17. Cui J, Eitzman DT, Westrick RJ, et al. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood 2000; 96: 4222-4226.
18. Van der Sluijs KF, Van Elden LJ, Arens R, et al. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus. Immunology 2005; 114: 112-120.
19. Elms MJ, Bundesen PG, Rowbury D, et al. Automated determination of cross-linked fibrin derivatives in plasma. Blood Coagul Fibrinolysis 1993; 4: 159-164.
20. Rijneveld AW, Levi M, Florquin S, et al. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol 2002; 168: 3507-3511.
21. Knapp S, Wieland CW, Florquin S, et al. Differential roles of CD14 and Toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am J Respir Crit Care Med 2006; 173: 122-129.
22. Rijneveld AW, Weijer S, Florquin S, et al. Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004; 103: 1702-1709.
23. Weijer S, Schoenmakers SH, Florquin S, et al. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J Infect Dis 2004; 189: 2308-2317.
24. Van Elden LJ, Nijhuis M, Schipper P, et al. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 2001; 39: 196-200.
25. Beigel JH. Influenza. Crit Care Med 2008; 36: 2660-2666.
26. Watanabe T, Yoshikawa H, Abe Y, et al. Renal involvement in children with influenza A virus infection. Pediatr Nephrol 2003; 18: 541-544. (Pubitemid 36790094)
27. Koster T, Rosendaal FR, Deronde H, et al. Venous thrombosis due to poor anticoagulant response to activated protein-C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506.
28. Russell JA. Genetics of coagulation factors in acute lung injury. Crit Care Med 2003; 31: S243-S247.
29. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol 2008; 3: 499-522.